How to Reconstitute Tirzepatide: Mixing, Dosing & Storage

You just received a vial of tirzepatide powder, a bottle of bacteriostatic water, and a box of insulin syringes — and suddenly the instructions feel way shorter than your anxiety about getting this wrong. That's a completely normal reaction. Reconstituting a peptide for the first time feels high-stakes. The good news: it's a repeatable, learnable process, and once you've done it once you'll do the next vial in under two minutes without a second thought.

5 min

Total reconstitution time

28–60 days

Shelf life once mixed

6–12 doses

From a single 30–60mg vial

Key Takeaways

Always use bacteriostatic water (BAC water) — not sterile water — for multi-dose vials; the benzyl alcohol preservative keeps bacteria out between injections.
Inject BAC water slowly down the vial wall, never directly onto the powder; high-pressure streams can damage the peptide structure.
Never shake a reconstituted vial. Gentle swirling only.
The most beginner-friendly concentration is 10 mg/mL (30 mg tirzepatide + 3 mL BAC water) — clean math, easy to dose.
Reconstituted tirzepatide lasts 28–60 days refrigerated; unreconstituted powder can be frozen for months without degradation.
Label every vial with the date reconstituted and the concentration before putting it in the fridge.

Once your vial is properly mixed, the rest of the protocol — pinching skin, injecting subcutaneously, rotating injection sites — is straightforward. This guide focuses entirely on getting the reconstitution step right so your doses are accurate from day one. If you haven't figured out your dose yet, check out our tirzepatide dosage guide before mixing. And if you still need to source your vials, our tirzepatide where to buy guide covers your options.

What Is Reconstitution (and Why Does It Matter)?

Compounded tirzepatide arrives as lyophilized powder — meaning it's been freeze-dried to strip out water and extend shelf life. Dry peptides are chemically stable. Dissolved peptides start degrading the moment water is introduced, which is why manufacturers ship the powder form.

Reconstitution reverses that process: you add a precise volume of bacteriostatic water to the powder, dissolve it, and create an injectable solution at a known concentration. If you get the volume wrong, every dose you pull from that vial is either too strong or too weak. If you damage the peptide during mixing, you're injecting an expensive liquid that doesn't work.

The steps below remove the guesswork.

Compounded Tirzepatide: What You're Actually Reconstituting

"Compounded tirzepatide" covers three different things, and which one is sitting on your table changes what the label on it is worth.

Where the vial came from	What it is	What the label tells you	What that means for mixing
503A compounding pharmacy	A state-licensed pharmacy compounding against a prescription for one named patient	Pharmacy name, patient name, strength, beyond-use date	The pharmacy's own reconstitution sheet outranks every chart on the internet, including this one
503B outsourcing facility	An FDA-registered facility compounding in batches, able to supply without a patient-specific prescription	Facility name, lot number, strength, beyond-use date	Same rule: the facility's instructions win, and the lot number is traceable
Vial sold "for research purposes" or "not for human consumption"	Sold outside the prescription system entirely	A peptide name, a milligram figure, sometimes a certificate of analysis	Nobody has verified that milligram figure on your behalf, and every unit in the tables below is only as accurate as it is

The legal position moved, and most mixing guides still describe 2024. FDA determined the tirzepatide injection shortage was resolved on December 19, 2024, which removed the condition that had made wide-scale compounding of tirzepatide copies permissible. The agency's enforcement-discretion windows then closed: February 18, 2025 for 503A state-licensed pharmacies and physicians, March 19, 2025 for 503B outsourcing facilities. In its April 1, 2026 update, FDA states that tirzepatide and semaglutide "do not currently appear on the 503B bulks list or on FDA's drug shortage list."

Compounded tirzepatide did not disappear, because two narrow doors stayed open:

A 503A pharmacy can still compound a product that differs from the approved drug in a way a prescriber determines and documents as a significant difference for an identified individual patient.
Separately, FDA has said it does not intend to take action against a compounder that fills four or fewer prescriptions of an essentially-a-copy product in a calendar month.

The trend is toward fewer doors, not more: on April 30, 2026 FDA proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list, finding no clinical need for outsourcing facilities to compound them from bulk substances, and invited comments through June 29, 2026 before making a final determination.

Why the agency cares about the exact step you are about to perform. FDA's stated concern with compounded GLP-1 products is not only what is in the vial — it is the arithmetic. The agency reports "multiple reports of adverse events, some requiring hospitalization, that may be related to dosing errors" with compounded injectable semaglutide products, errors that "resulted from patients measuring and self-administering incorrect doses of the drug, and in some cases, health care professionals miscalculating doses of the drug." It has separately received reports tied to patients prescribed compounded semaglutide or tirzepatide "in doses beyond what is in the FDA-approved drug label." As of May 31, 2026, FDA had received more than 730 adverse event reports associated with compounded tirzepatide and 990 associated with compounded semaglutide.

That is exactly why every table on this page names the vial strength, the diluent volume and the syringe type together. A number of units means nothing without all three. FDA has also warned companies selling unapproved semaglutide, tirzepatide or retatrutide labeled "for research purposes" or "not for human consumption" and then sold to consumers with dosing instructions — a description worth holding up against whatever paperwork came with your vial.

One transit note while you are checking the vial: FDA's warning about injectable GLP-1 products arriving warm or with inadequate ice packs applies to ready-to-inject solutions, which require refrigeration under their package inserts. Lyophilized powder is more forgiving in the mail. The moment you add BAC water, it stops being forgiving and the cold-chain rules in the storage section below apply.

For the sourcing and cost side of this decision, the Middleway Nutrition guide to compounded tirzepatide goes deeper than this page does.

What You'll Need: Full Supplies List

Get everything on the table before you open anything. Mid-process fumbling is where contamination happens.

Required:

Tirzepatide vial (lyophilized powder — white to off-white cake inside)
Bacteriostatic water (BAC water) — look for "0.9% benzyl alcohol" on the label
Insulin syringes, U-100, 0.5 mL or 1 mL (for drawing doses)
A 3 mL syringe + 18–23 gauge needle (for transferring BAC water into the peptide vial)
Alcohol swabs (isopropyl, 70%)
Sharps container

Strongly recommended:

Permanent marker or label tape (to write date + concentration on vial)
Nitrile gloves
A clean, flat surface wiped with an alcohol swab

One quick note on syringes: The larger 3 mL syringe is only for the initial BAC water transfer. Your actual injections use the smaller insulin syringe. Don't mix them up.

Why Bacteriostatic Water — Not Just Any Water

If you've seen "sterile water for injection" at the pharmacy and wondered whether it works, technically it does — but only for single-use vials. Sterile water has no preservative, so bacteria can grow in it within hours. A 30 mg tirzepatide vial gives you 6+ doses over several weeks. You need BAC water's benzyl alcohol content to prevent contamination between uses.

Tap water, distilled water, or saline are never appropriate substitutes. Wrong pH, wrong osmolarity, potential contaminants — all of these can precipitate the peptide or damage it.

BAC water is inexpensive and available from most peptide suppliers, compounding pharmacies, and online retailers. If you're sourcing your tirzepatide from Synthro Lab, BAC water is typically available in the same order.

The BAC Water Volume Formula

This is the math that trips people up. Here's the simple version:

Concentration (mg/mL) = Vial Size (mg) ÷ BAC Water Volume (mL)

Flip that around to choose your BAC water volume:

BAC Water Volume (mL) = Vial Size (mg) ÷ Target Concentration (mg/mL)

Example: You have a 30 mg vial and want a 10 mg/mL concentration. → 30 ÷ 10 = 3 mL BAC water

The most common target concentration is 5 mg/mL or 10 mg/mL because these produce round numbers when you're calculating insulin syringe units. Avoid concentrations like 3.33 mg/mL — the dosing math becomes painful.

Concentration Calculator Table

Vial Size	BAC Water	Concentration	2.5 mg dose	5 mg dose	7.5 mg dose	10 mg dose
5 mg	1 mL	5 mg/mL	50 IU	100 IU	—	—
10 mg	2 mL	5 mg/mL	50 IU	100 IU	150 IU	200 IU
15 mg	3 mL	5 mg/mL	50 IU	100 IU	150 IU	200 IU
30 mg	3 mL	10 mg/mL	25 IU	50 IU	75 IU	100 IU
30 mg	6 mL	5 mg/mL	50 IU	100 IU	150 IU	200 IU
45 mg	3 mL	15 mg/mL	17 IU	33 IU	50 IU	67 IU
60 mg	6 mL	10 mg/mL	25 IU	50 IU	75 IU	100 IU
60 mg	12 mL	5 mg/mL	50 IU	100 IU	150 IU	200 IU

IU = insulin units on a U-100 syringe. The 100 IU mark on a U-100 insulin syringe = 1 mL of liquid. So 50 IU = 0.5 mL, 25 IU = 0.25 mL, etc.

What every row assumes: concentration = vial strength (mg) ÷ BAC water volume (mL); units to draw = (dose mg ÷ concentration mg/mL) × 100; syringe = U-100 insulin syringe, where 100 units = 1 mL. Change the vial strength or the diluent volume and every unit figure on that row changes with it.

Two things the table cannot tell you on its own:

Anything above 100 units does not fit in one syringe. A 1 mL U-100 insulin syringe tops out at exactly 100 units. The 150 IU and 200 IU cells are arithmetically correct, but in practice they mean two draws and two injections, or a subcutaneous volume larger than most people want to push. If your dose lands above 100 units, the fix is less diluent — 30 mg in 3 mL rather than 30 mg in 6 mL — not a bigger syringe.
The 15 mg/mL row rounds, the others don't. At 45 mg in 3 mL, 2.5 mg is 16.7 units and 5 mg is 33.3 units. Drawing 17 and 33 units delivers 2.55 mg and 4.95 mg — within 2% in both directions, fine in practice, and the reason this guide steers you toward 5 mg/mL or 10 mg/mL, where every standard dose lands on a whole mark.

How to Calculate Units Per Dose

Once you know your concentration, the formula for finding how many IU to draw is:

IU to draw = (Desired Dose mg ÷ Concentration mg/mL) × 100

Example: You want a 5 mg dose from a 30 mg vial reconstituted with 3 mL BAC water (10 mg/mL). → (5 ÷ 10) × 100 = 50 IU

On a U-100 insulin syringe, find the 50 mark. That's your dose.

If your dose is 2.5 mg and your concentration is 5 mg/mL: → (2.5 ÷ 5) × 100 = 50 IU

Same units, different concentration — because the ratio changes. This is why locking in your concentration first makes everything cleaner.

Step-by-Step Reconstitution Process

Lay out your supplies. Wipe down your work surface with an alcohol swab. Now go through these steps in order — don't skip ahead.

Step 1 — Wash your hands Soap and warm water, at least 20 seconds. If you have nitrile gloves, put them on after washing. This is the single highest-impact contamination prevention step.

Step 2 — Swab both vial tops Use a fresh alcohol swab on the rubber stopper of your tirzepatide vial. Use another swab on the BAC water vial stopper. Let both dry for 10–15 seconds — wet alcohol can introduce liquid into your vials.

Step 3 — Draw air into the 3 mL syringe Pull back the plunger to draw air equal to the volume of BAC water you're about to transfer (e.g., 3 mL for a 30 mg vial). This equalizes pressure in the BAC water vial when you insert the needle.

Step 4 — Transfer BAC water into the syringe Insert the needle through the BAC water vial's rubber stopper. Inject the air, then invert the vial and slowly draw out your target volume of BAC water. Check for bubbles; tap the syringe and push them back if needed.

Step 5 — Inject BAC water into the tirzepatide vial — SLOWLY This is the most important step. Insert the needle through the tirzepatide vial's stopper at an angle so the tip of the needle touches the inside wall of the glass. Inject the BAC water very slowly, letting it trickle down the vial wall. Do not squirt it directly onto the powder cake.

Why? A high-pressure jet of liquid can physically break peptide bonds. A slow trickle dissolves the powder gently from the side.

Step 6 — Gently swirl (do not shake) Once all the BAC water is in, put the cap back on and gently swirl the vial in a slow circular motion. Don't shake. Don't invert it rapidly. The powder should fully dissolve in 1–5 minutes into a clear, colorless solution.

If after 10 minutes you still see cloudiness or undissolved particles, do not use the vial. Contact your supplier.

Step 7 — Label the vial immediately Write on the label or tape: the date of reconstitution, the concentration (e.g., "10 mg/mL"), and a discard date (28 days from today for conservative storage, or 60 days if you're confident in your cold chain).

Step 8 — Refrigerate Store the vial immediately at 36–46°F (2–8°C). Do not leave it sitting on the counter.

How Many Doses Per Vial?

This depends on your dose and the vial size. The formula:

Doses per Vial = Vial Size (mg) ÷ Dose per Injection (mg)

Vial Size	2.5 mg/dose	5 mg/dose	7.5 mg/dose	10 mg/dose
5 mg	2 doses	1 dose	—	—
10 mg	4 doses	2 doses	1 dose	1 dose
15 mg	6 doses	3 doses	2 doses	1 dose
30 mg	12 doses	6 doses	4 doses	3 doses
60 mg	24 doses	12 doses	8 doses	6 doses

At weekly injections, a 30 mg vial at 5 mg/dose = 6 weeks of supply. A 60 mg vial at 5 mg/dose = 12 weeks. That's useful context when comparing prices per vial at different sizes.

Storage: Reconstituted vs. Unreconstituted Powder

These two storage situations are completely different and get confused constantly.

State	Temperature	Duration	Light	Freeze?
Unreconstituted powder	Room temp or refrigerator	Up to 12–24 months (check label)	Avoid direct sunlight	✅ Yes — freezing extends life
Reconstituted solution	36–46°F (2–8°C) — refrigerator only	28–60 days	Keep vial away from light	❌ Never freeze

Freezing reconstituted tirzepatide ruins it. Ice crystal formation physically damages the peptide's three-dimensional structure and can cause aggregation. Once the vial is reconstituted, the refrigerator is the only safe storage location.

Freezing unreconstituted powder is fine — and actually extends shelf life significantly if you're stocking up. Just let frozen powder warm slowly to room temperature before adding BAC water; injecting cold water into a cold vial can cause precipitation.

Signs of Degradation: When Not to Use It

Before every injection, spend 5 seconds visually inspecting the vial. Discard it if you see any of the following:

Cloudiness or haze — a properly reconstituted vial is crystal clear
Visible particles or floating flakes — peptide aggregation or contamination
Yellow or brown tinting — oxidation, usually from temperature excursion
Unusual smell when you open the vial for inspection (should be neutral/faint)
Foamy texture that doesn't clear within a few minutes
Past discard date — even if it looks fine, don't risk it

A clear solution that's been stored correctly is safe to use. If anything looks off, the cost of wasting one vial is far less than the cost of injecting a contaminated or degraded solution.

Common Reconstitution Mistakes (and How to Avoid Them)

Squirting BAC water directly onto the powder The most common mistake. Use the vial wall technique every single time.

Shaking the vial It feels intuitive — you want the powder to mix, right? But shaking creates mechanical stress that fragments peptide chains. Swirl, don't shake.

Using sterile water for a multi-dose vial No benzyl alcohol = no bacterial protection = contamination risk by the second or third dose. BAC water is the correct choice here.

Wrong concentration math Some people mix their BAC water volume without writing it down, then forget what concentration they used. You will be returning to this vial for weeks. Write the concentration on the label before you even put it in the fridge.

Leaving the vial at room temperature Some people pull the vial out, draw a dose, and then leave the vial on the counter while they inject. Put the vial back in the fridge immediately after drawing. Every minute at room temperature accelerates degradation.

Using a needle that's too large for the rubber stopper Repeatedly coring a rubber stopper with an 18-gauge needle causes small rubber particles to fall into the solution. Use the smallest gauge that draws smoothly — typically 23 gauge for BAC water transfer is fine.

Not inspecting the solution before each injection Get into the habit. It takes five seconds and could save you from injecting something that's gone bad.

Frequently Asked Questions

How much BAC water do I add to a 30 mg tirzepatide vial? The recommended amount is 3 mL, which gives you a 10 mg/mL concentration. This makes dosing math straightforward: 2.5 mg = 25 IU, 5 mg = 50 IU, 7.5 mg = 75 IU, 10 mg = 100 IU. If you prefer a different concentration, use the formula: BAC water (mL) = vial size (mg) ÷ target concentration (mg/mL).

Can I use sterile water instead of bacteriostatic water? Only if you're using the entire vial in a single session. Sterile water has no preservative, so it cannot safely be stored for multi-dose use. For any vial you'll use across multiple injections — which is virtually every compounded tirzepatide vial — BAC water is the correct choice.

What does the reconstituted solution look like? It should be completely clear and colorless — like water. No cloudiness, no particles, no color. If it looks anything other than crystal clear, don't inject it.

How long does reconstituted tirzepatide last in the fridge? The conservative recommendation is 28 days. Many sources cite 60 days as the outer limit for properly stored, quality BAC water reconstitutions. Label your vial with a discard date at reconstitution and stick to it.

Can I freeze the reconstituted vial to extend its life? No. Freezing damages the peptide structure. Once reconstituted, refrigeration only. The powder form (before mixing) can be safely frozen to extend storage life significantly.

What if the powder doesn't fully dissolve? Swirl gently for up to 10 minutes. Tirzepatide powder typically dissolves fully within 1–5 minutes in BAC water at room temperature. If you're working with a cold vial (just out of the freezer), let it warm up first. If it still won't dissolve after 10 minutes of gentle swirling, the powder may be degraded — contact your supplier.

Is compounded tirzepatide still legal in 2026? Narrowly, and not on the basis it used to be. FDA declared the tirzepatide shortage resolved on December 19, 2024, and its enforcement-discretion windows closed on February 18, 2025 for 503A pharmacies and March 19, 2025 for 503B outsourcing facilities. Compounding did not become impossible: a 503A pharmacy can still prepare a product that a prescriber determines and documents as significantly different for an individual patient, and FDA has said it does not intend to act against a compounder filling four or fewer essentially-a-copy prescriptions in a calendar month. What changed is that "the drug is in shortage" is no longer available as the justification — and in April 2026 FDA proposed removing tirzepatide from the 503B bulks list altogether.

What's the difference between compounded tirzepatide and Mounjaro/Zepbound? FDA-approved Mounjaro and Zepbound come in pre-filled autoinjector pens — no reconstitution needed. Compounded tirzepatide comes as lyophilized powder and requires mixing. The active molecule is tirzepatide in both cases. Compounded versions are typically less expensive and more accessible but are not FDA-approved finished drug products.

Do I need to reconstitute tirzepatide if I get the brand-name version? No. Mounjaro and Zepbound pens are pre-filled and ready to use. This guide applies to compounded tirzepatide in powder form only.

How to mix tirzepatide powder with BAC water to make a 5mg weekly injection? To mix tirzepatide powder with BAC water for a 5mg weekly injection: start with a standard 30mg vial, add 3 mL of BAC water (giving 10 mg/mL concentration), swirl gently until fully dissolved. To draw your 5mg weekly dose, pull 0.5 mL = 50 units on a U-100 insulin syringe. This is the same step-by-step a ChatGPT prompt would return — verify each time with the math: dose in mg ÷ concentration in mg/mL = mL to draw, then mL × 100 = units. The 5mg weekly dose is typically reached around week 5–8 of a standard titration.

Want to Mix Something Similar? Here's More Help

If you're also working with retatrutide, the reconstitution process is nearly identical — see our how to reconstitute retatrutide guide for the specifics.

Ready to Order Quality Tirzepatide?

Getting the reconstitution right starts with sourcing a clean, accurately dosed product. We recommend Synthro Lab — triple-tested every batch to at least 99% HPLC purity, a certificate of analysis with every order, same-day dispatch, and BAC water available in the same order.

Medical disclaimer: The information in this article is for educational purposes only. Tirzepatide is a prescription medication. This content does not constitute medical advice, diagnosis, or treatment. Consult a licensed healthcare provider before using any medication or peptide compound. Always follow applicable laws and regulations in your jurisdiction.